Omini Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$5M
- Investors
-
14
Omini General Information
Description
Developer of a point-of-care blood-testing platform designed to support chronic disease monitoring and therapy management. The company offers portable multiplex blood testing, a reusable reader, single-use testing strips, a companion app, and secure cloud connectivity, enabling healthcare providers, to monitor patients and manage chronic disease treatment.
Contact Information
Website
www.ominilabs.comCorporate Office
- 9 rue Noel Pons
- 92000 Nanterre
- France
Corporate Office
- 9 rue Noel Pons
- 92000 Nanterre
- France
Omini Timeline
Omini Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC | $5M | Completed | Generating Revenue | |||
| 11. Accelerator/Incubator | 27-May-2026 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | 01-Jan-2026 | Completed | Generating Revenue | |||
| 9. Grant | 01-Jan-2025 | Completed | Generating Revenue | |||
| 8. Grant | 01-Jan-2024 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | Completed | Product In Beta Test | ||||
| 6. Accelerator/Incubator | 01-Jan-2022 | Completed | Product In Beta Test | |||
| 5. Grant | 10-Apr-2021 | Completed | Product In Beta Test | |||
| 4. Seed Round | 15-Dec-2020 | $1.06M | $1.16M | Completed | Product In Beta Test | |
| 3. Grant | 31-Jul-2020 | $130K | $103K | Completed | Product In Beta Test |
Omini Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Omini Comparisons
Industry
Financing
Details
Omini Competitors (4)
One of Omini’s 4 competitors is Jana Care, a Venture Capital-Backed company based in Watertown, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Jana Care | Venture Capital-Backed | Watertown, MA | ||||
| Siemens Healthineers | Corporation | Forchheim, Germany | ||||
| Abbott | Corporation | Abbot Park, IL | ||||
| Nova Biomedical | Private Equity-Backed | Waltham, MA |
Omini Signals
Omini Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MedTech Innovator | Accelerator/Incubator | |||
| HeartX Accelerator | Accelerator/Incubator | |||
| European Innovation Council | Accelerator/Incubator | |||
| Neighborhood | Accelerator/Incubator | |||
| Angels Santé | Angel Group | Minority |
Omini FAQs
-
When was Omini founded?
Omini was founded in 2019.
-
Where is Omini headquartered?
Omini is headquartered in Nanterre, France.
-
What is the size of Omini?
Omini has 12 total employees.
-
What industry is Omini in?
Omini’s primary industry is Diagnostic Equipment.
-
Is Omini a private or public company?
Omini is a Private company.
-
What is Omini’s current revenue?
The current revenue for Omini is .
-
How much funding has Omini raised over time?
Omini has raised $6.31M.
-
Who are Omini’s investors?
MedTech Innovator, HeartX Accelerator, European Innovation Council, Neighborhood, and Angels Santé are 5 of 14 investors who have invested in Omini.
-
Who are Omini’s competitors?
Jana Care, Siemens Healthineers, Abbott, and Nova Biomedical are competitors of Omini.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process